Vessey M P, Villard-Mackintosh L, Painter R
Department of Public Health and Primary Care, Radcliffe Infirmary, Oxford.
BMJ. 1993 Jan 16;306(6871):182-4. doi: 10.1136/bmj.306.6871.182.
To describe the epidemiology of endometriosis in women attending family planning clinics with special reference to contraceptive methods.
Non-randomised cohort study with follow up of subjects for up to 23 years. Disease was measured by first hospital admission rates since endometriosis can be diagnosed with accuracy only at laparotomy or laparoscopy.
17 family planning centres in England and Scotland.
17,032 married white women aged 25-39 years at entry during 1968-74 who were taking oral contraceptives or using an intrauterine device or diaphragm. About 99% of the women approached agreed to participate and annual loss to follow up was about 0.3%.
Diagnosis of endometriosis, age, parity, and history of contraceptive use.
Endometriosis was significantly related to age, peaking at ages 40-44 (chi 2 for heterogeneity = 30.9, p < 0.001). Endometriosis was not linked to duration of taking oral contraceptives. Nevertheless, the risk of endometriosis was low in women currently taking oral contraceptives (relative risk 0.4; 95% confidence interval 0.2 to 0.7), but higher in women who had formerly taken them (1.8; 1.0 to 3.1 in women who had stopped 25-48 months previously) compared with women who had never taken the pill. A similar pattern was seen for use of intrauterine devices (relative risk 0.4 (0.2 to 0.7) in current users and 1.4 (0.4 to 3.2) in users 49-72 months previously compared with never users). No association was found between endometriosis and use of the diaphragm.
Oral contraceptives seem to temporarily suppress endometriosis. Endometriosis may be diagnosed late in women using intrauterine devices as pain and bleeding occur with both.
描述在计划生育诊所就诊的女性子宫内膜异位症的流行病学情况,并特别提及避孕方法。
非随机队列研究,对受试者进行长达23年的随访。由于子宫内膜异位症只有在剖腹手术或腹腔镜检查时才能准确诊断,因此通过首次入院率来衡量疾病情况。
英格兰和苏格兰的17个计划生育中心。
1968年至1974年间,17032名年龄在25至39岁之间的已婚白人女性,她们正在服用口服避孕药、使用宫内节育器或子宫托。约99%被邀请的女性同意参与,每年的失访率约为0.3%。
子宫内膜异位症的诊断、年龄、产次和避孕使用史。
子宫内膜异位症与年龄显著相关,在40至44岁达到峰值(异质性卡方值=30.9,p<0.001)。子宫内膜异位症与口服避孕药的服用时长无关。然而,目前服用口服避孕药的女性患子宫内膜异位症的风险较低(相对风险0.4;95%置信区间0.2至0.7),但与从未服用过避孕药的女性相比,曾经服用过的女性患子宫内膜异位症的风险更高(停药25至48个月的女性为1.8;1.0至3.1)。使用宫内节育器的情况也呈现类似模式(与从未使用者相比,当前使用者的相对风险为0.4(0.2至0.7),49至72个月前使用者的相对风险为1.4(0.4至3.2))。未发现子宫内膜异位症与子宫托的使用之间存在关联。
口服避孕药似乎能暂时抑制子宫内膜异位症。使用宫内节育器的女性可能因疼痛和出血症状而导致子宫内膜异位症诊断延迟,因为这两种情况都会出现这些症状。